Table 1 Baseline demographic, laboratory and echocardiographic characteristics

Age, y

59.3 ± 12.7

59.61 ± 13.06

59.13 ± 12.58

57.65 ± 12.52

60.04 ± 12.82

Male, n (%)

50 (48.5)

21 (51.22)

29 (46.77)

20 (64.52)

30 (41.67)

Diabetes Mellitus, n (%)

63 (61.2)

28 (68.29)

35 (56.45)

23 (74.19)

40 (55.56)

Hypertension, n (%)

101 (98.1)

40 (97.56)

61 (98.39)

30 (96.77)

71 (98.61)

Dyslipidemia, n (%)

78 (75.7)

30 (73.17)

48 (77.42)

19 (61.29)

59 (81.94)

Smoker, n (%)

23 (22.3)

4 (9.76)

19 (30.65)

8 (25.81)

15 (20.83)

Previous CAD, n (%)

20 (19.4)

11 (26.83)

9 (14.52)

5 (16.13)

15 (20.83)

Pulmonary disease, n (%)

2 (1.9)

0

2 (3.23)

1 (3.23)

1 (1.39)

SBP, mmHg

150.7 ± 23.0

148.54 ± 21.27

152.19 ± 24.15

144.03 ± 18.77

153.63 ± 24.16

DBP, mmHg

82.6 ± 12.7

83.54 ± 15.49

82.03 ± 10.62

81.55 ± 13.55

83.09 ± 12.43

BMI, Kg/m²

24.2 ± 3.6

23.57 ± 3.65

24.59 ± 3.62

23.77 ± 3.18

24.36 ± 3.84

BSA, m²

1.20 ± 0.10

1.19 ± 0.09

1.18 ± 0.09

1.22 ± 0.09

1.18 ± 0.09

Duration of CAPD, months^a

12.0 (3.0, 24.0)

11.0 (4.0, 23.0)

12.0 (3.0, 24.0)

9.0 (2.0, 18.0)

13.5 (4.25, 28.50)

 NLR ^a

3.3 (2.3, 4.3)

4.9 (3.9, 5.8)

2.5 (2.0, 3.2)

5.2 (3.4, 8.8)

2.9 (2.2, 3.6)

 PLR ^a

164.1 (119.0, 231.6)

168.1 (109.8, 246.9)

97.1 (68.9, 128.5)

203.5 (168.75, 271.8)

95.9 (68.8, 120.7)

 Hb; g/dl

10.4 ± 1.8

10.4 ± 1.8

10.4 ± 1.8

10.2 ± 2.1

10.6 ± 1.6

 Serum creatinine; g/dL

8.9 ± 3.1

8.7 ± 2.8

9.1 ± 3.3

8.9 ± 2.9

8.9 ± 3.2

 GFR (CKD-EPI)^a;ml/min/1.73m²

5.3 (4.0, 6.9)

6.1 ± 2.9

6.1 ± 5.0

6.1 ± 2.7

6.1 ± 4.8

 Serum albumin; g/dL

3.4 ± 0.5

3.2 ± 0.5

3.6 ± 0.5

3.1 ± 0.6

3.6 ± 0.5

 Serum calcium; mg/dL

8.4 ± 0.9

8.2 ± 1.1

8.6 ± 0.8

8.0 ± 0.9

8.6 ± 0.9

 Serum phosphate; mg/dL

4.8 ± 1.5

4.6 ± 1.4

4.9 ± 1.5

4.9 ± 1.6

4.7 ± 1.4

 QTc interval; msec

459.5 ± 43.2

460.4 ± 48.6

458.9 ± 39.5

468.6 ± 47.8

455.5 ± 40.7

 LVSD

18 (17.48)

11 (26.83)

7 (11.29)

9 (29.03)

9 (12.50)

 LVEF ^b; %

59.5 + 10.9

56.0 ± 12.3

61.7 ± 9.4

55.2 ± 11.2

61.3 ± 10.4

 LVEDD; mm

49.5 ± 8.3

49.6 ± 8.6

49.5 ± 8.2

50.9 ± 8,1

48.9 ± 8.4

 LVESD; mm

32.9 ± 8.5

34.5 ± 9.3

31.9 ± 7.8

34.9 ± 8.9

32.1 ± 8.2

 LAVI; ml/m²

51.2 ± 20.9

53.7 ± 28.7

51.3 ± 19.4

53.4 ± 22.1

51.8 ± 24.1

 LVMI; g/m²

205.1 ± 78.7

206.9 ± 79.2

203.9 ± 78.9

216.8 ± 82.3

200.1 ± 77.2

 IVSD; mm

12.1 ± 2.3

12.2 ± 2.3

11.9 ± 2.4

12.4 ± 2.7

11.9 ± 2.2

 IVSS; mm

15.1 ± 2.4

15.1 ± 2.5

15.1 ± 2.4

15.5 ± 2.9

14.9 ± 2.2

 Mitral E/A

0.7 (06, 0.9)

0.7 (0.6, 0.9)

0.7 (0.6, 1.1)

0.8 (0.6, 1.2)

0.7 (0.6, 0.9)

 Mitral E/e’

18.5 ± 8.5

20.4 ± 10.9

17.2 ± 6.2

19.4 ± 10.4

18.1 ± 10.5

 RVSP; mmHg

42.9 ± 14.1

43.6 ± 15.6

42.5 ± 13.2

45.4 ± 14.7

41.8 ± 13.8

 TAPSE; cm

2.3 ± 0.5

2.1 ± 0.5

2.4 ± 0.5

2.2 ± 0.6

2.4 ± 0.5